Vectors Research Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-9,189
Closed -$673K 132
2024
Q1
$673K Sell
9,189
-269
-3% -$20.7K 0.19% 95
2023
Q4
$767K Sell
9,458
-165
-2% -$12.8K 0.22% 92
2023
Q3
$690K Sell
9,623
-27
-0.3% -$2.08K 0.22% 84
2023
Q2
$744K Sell
9,650
-446
-4% -$35.6K 0.21% 87
2023
Q1
$838K Sell
10,096
-194
-2% -$16.1K 0.22% 85
2022
Q4
$883K Sell
10,290
-342
-3% -$27.1K 0.23% 80
2022
Q3
$656K Sell
10,632
-118
-1% -$7.44K 0.19% 88
2022
Q2
$664K Sell
10,750
-286
-3% -$17.7K 0.17% 96
2022
Q1
$656K Sell
11,036
-496
-4% -$31.7K 0.14% 104
2021
Q4
$837K Buy
11,532
+543
+5% +$37.4K 0.18% 96
2021
Q3
$768K Buy
10,989
+320
+3% +$22.5K 0.18% 98
2021
Q2
$735K Buy
10,669
+254
+2% +$17K 0.19% 96
2021
Q1
$673K Buy
10,415
+9,094
+688% +$586K 0.19% 99
2020
Q4
$77K Sell
1,321
-46
-3% -$2.78K 0.02% 175
2020
Q3
$84K Sell
1,367
-999
-42% -$69.3K 0.03% 153
2020
Q2
$182K Sell
2,366
-185
-7% -$14.2K 0.07% 119
2020
Q1
$191K Hold
2,551
0.09% 106
2019
Q4
$166K Hold
2,551
0.07% 118
2019
Q3
$162K Hold
2,551
0.08% 118
2019
Q2
$172K Hold
2,551
0.09% 110
2019
Q1
$166K Sell
2,551
-100
-4% -$6.65K 0.09% 110
2018
Q4
$166K Buy
2,651
+157
+6% +$11K 0.08% 118
2018
Q3
$178K Buy
+2,494
New +$188K 0.11% 110

Other funds holding GILD

Vectors Research Management's GILD Position: Q2 2024 in Review

Vectors Research Management sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 9,189 shares — an estimated $673K sold.

Vectors Research Management first reported a position in GILD in Q3 2018 and held it in 23 quarters. The position peaked at $883K in Q4 2022. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

  • Vectors Research Management reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
  • Vectors Research Management sold 9,189 Gilead Sciences shares in Q2 2024, an estimated $673K.
  • Vectors Research Management first reported a position in Gilead Sciences in Q3 2018 and held it in 23 quarters.
  • Vectors Research Management's Gilead Sciences position peaked at $883K in Q4 2022.
  • 1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on Vectors Research Management's 13F filing for Q2 2024, filed 9 Aug 2024.